August 20, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

Kff Health News

August 13, 2026

Can GH therapy improve final height after HCT?

Growth gains continued beyond the first year of treatment, while irradiation and other transplant-related factors influenced response.

MDSpire News

August 12, 2026

How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.

MDSpire News

August 07, 2026

Adrenal Tumor Patients Need the Multidisciplinary Care Roswell Park Provides

Adrenal cortical carcinomas are rare, diagnosed in only one or two people per million annually, but are also more likely to be found at a later state because they are largely asymptomatic.

Roswell Park Comprehensive Cancer Center

July 20, 2026

Mutant KRAS Vaccine for Prevention of Pancreatic Cancer Development Shows Durable Immune Responses

A vaccine targeting common KRAS mutations was safe and stimulated KRAS-specific T-cell responses in 90% of study participants who were at high risk of developing pancreatic ductal adenocarcinoma, acco...

The ASCO Post

July 20, 2026

GLP-1 Receptor Agonists May Reduce Metastatic Progression in Certain Obesity-Related Cancers

Real-world data suggest that GLP-1 receptor agonists may reduce metastatic progression in certain obesity-related cancers, particularly lung, breast, colorectal, and liver cancers, according to findin...

The ASCO Post

July 16, 2026

How Do Surgical Ovarian Cancer Prevention Strategies Compare for Sexual Function?

A nonrandomized trial found less sexual function impairment with interval salpingectomy with delayed oophorectomy than risk-reducing salpingo-oophorectomy among premenopausal women at high risk for ov...

The ASCO Post

July 16, 2026

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

MDSpire News

July 13, 2026

Advanced Breast Cancer: Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor

In an interim analysis of a Chinese phase III trial (FCN-437c-III201) reported in JAMA Oncology, Yuan et al found that the addition of the novel CDK4/6 inhibitor fovinaciclib to aromatase inhibitor th...

The ASCO Post

July 13, 2026

Advanced Breast Cancer: Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor

In an interim analysis of a Chinese phase III trial (FCN-437c-III201) reported in JAMA Oncology, Yuan et al found that the addition of the novel CDK4/6 inhibitor fovinaciclib to aromatase inhibitor th...

The ASCO Post